Fidelity SPDR Advertisement
Home > Boards > Free Zone > Big Board Trading - Technical > *SCALPSWINGSTRADDLE* ($$$)

Pharmacyclics pullback a buying opportunity, says Credit Suisse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
madrose1 Member Profile
Member Level 
Followed By 297
Posts 47,229
Boards Moderated 10
Alias Born 04/07/01
160x600 placeholder
Guard Shot Near Canada Parliament
Canada's parliament building and other government offices are locked down in Ottawa after an armed attack left at least one injured guard at the country's main war memorial.
More Top Equities Stories Of The Day
Hong Kong Protests Expose Differences in Local Media
FTSE 100 Climbs As Oil Stocks Advance
Correction to AT&T Earnings Preview Story
Airbus 'Actively Discussing' New A321neo With Airlines -Reuters
Stifel Financial to Hire Two Former Merrill Lynch Advisers
Five HP Executives Sell $12.3 Million in Stock -- Barron's
U.S. Stocks Gain, but IBM Weighs on Dow
EU Seeks Trans-Atlantic Air Pact Feedback
madrose1 Member Level  Monday, 03/25/13 08:37:55 AM
Re: None
Post # of 647625 
Pharmacyclics pullback a buying opportunity, says Credit Suisse
Credit Suisse would use the pullback in Pharmacyclics as a buying opportunity given the multi-billion dollar potential of ibrutinib. Shares are Outperform rated with a $90 price target

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist